About
Umbrella company acquiring drug companies
Areas of Focus
Categories
Biologics & BiopharmaceuticalSmall Molecule PharmaceuticalAntibodyBoston & New England
Team (3)
Clinical Trials (14)
View allTotal Trials
14
As Lead Sponsor
4
As Collaborator
10
Total Enrollment
789
By Phase
PHASE2: 4PHASE1: 3PHASE3: 4PHASE1/PHASE2: 2
By Status
TERMINATED: 10RECRUITING: 3COMPLETED: 1
Clinical Trials Pipeline14 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT07096674Lead Sponsor
A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
PHASE2Recruiting
90 participants
Started: Aug 12, 2025 · Completed: Apr 30, 2026
NCT07082829Lead Sponsor
A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age
PHASE1Recruiting
208 participants
Started: Jun 30, 2025 · Completed: Dec 31, 2025
NCT06752668Lead Sponsor
A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
PHASE2Recruiting
96 participants
Started: Dec 23, 2024 · Completed: Dec 31, 2025
NCT06568302Collaborator
The Long-term Safety and Efficacy of SerpinPC in Subjects with Hemophilia Who Completed a Sponsored SerpinPC Clinical Trial
PHASE3Terminated
15 participants
Started: Jul 11, 2024 · Completed: Jan 29, 2025
NCT05789537Collaborator
A Study of SerpinPC in Participants with Hemophilia B (HemB) with Inhibitors
PHASE2Terminated
3 participants
Started: Jul 28, 2023 · Completed: Feb 24, 2025
Locations (1)
Headquarters
Boston, MA, United States
Map
Loading map...